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Abstract
This study tested the hypothesis that baroreceptor unloading during passive hyperthermia 
contributes to increases in ventilation and decreases in end-tidal partial pressure of carbon dioxide 
 during that exposure. Two protocols were performed, in which healthy subjects 
underwent passive hyperthermia (increasing intestinal temperature by ~1.8°C) to cause a sustained 
increase in ventilation and reduction in . Upon attaining hyperthermic hyperventilation, in 
protocol 1 (n = 10; three females) a bolus (19 ± 2 ml kg−1) of warm (~38°C) isotonic saline was 
rapidly (5–10 min) infused intravenously to restore reductions in central venous pressure, whereas 
in protocol 2 (n = 11; five females) phenylephrine was infused intravenously (60–120 μg min−1) to 
return mean arterial pressure to normothermic levels. In protocol 1, hyperthermia increased 
ventilation (by 2.2 ± 1.7 l min−1, P < 0.01), while reducing  (by 4 ± 3 mmHg, P = 0.04) 
and central venous pressure (by 5 ± 1 mmHg, P <0.01). Saline infusion increased central venous 
pressure by 5 ± 1 mmHg (P < 0.01), restoring it to normothermic values, but did not change 
ventilation or  (P > 0.05). In protocol 2, hyperthermia increased ventilation (by 5.0 ± 2.7l 
min−1, P <0.01) and reduced  (by 5 ± 2 mmHg, P < 0.01) and mean arterial pressure (by 9 
± 7 mmHg, P <0.01). Phenylephrine infusion increased mean arterial pressure by 12 ± 3 mmHg (P 
< 0.01), restoring it to normothermic values, but did not change ventilation or  (P > 0.05). 
The absence of a reduction in ventilation upon reloading the cardiopulmonary and arterial 
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baroreceptors to pre-hyperthermic levels indicates that baroreceptor unloading with hyperthermia 
is unlikely to contribute to hyperthermic hyperventilation in humans.
 Introduction
Hyperthermic hyperventilation is well documented in humans and is associated with high 
skin and body core temperatures (Tcore, in excess of +1.0°C; Cabanac & White, 1995; Fujii 
et al. 2008b). Given the relatively minor contribution of respiratory heat loss with respect to 
human heat balance, the mechanism(s) and/or the physiological relevance of hyperthermic 
hyperventialtion in humans are unclear. Previous mechanisms proposed to contribute to this 
response in humans include selective brain cooling (White, 2006), heightened 
chemoreceptor sensitivity (Fujii et al. 2008a) and increases in cutaneous vasodilatation 
(Hayashi et al. 2009). However, the effectiveness of respiratory heat dissipation in the 
absence of cooling devices (i.e. face fanning or nasopharyngeal coolant spray) challenges 
the validity of selective brain cooling (Nybo & Secher, 2011). Furthermore, chemoreceptors 
contribute little to hyperthermic hyperventilation (Fujii et al. 2008a), and enhanced skin 
vasodilatation via heat acclimatization does not alleviate hyperthermic hyperventilation 
(Fujii et al. 2012). Rapid skin surface cooling (excluding the head) restores  and 
presumably reverses hyperventilation during severe hyperthermia (Lucas et al. 2010). 
However, it is unknown whether this is due to a cold-induced pressor response and 
subsequent loading of the baroreceptors (Wilson et al. 2007a).
Hyperventilation is also triggered by hypotension in normothermic (Convertino et al. 2009; 
Thomas et al. 2009; Stewart et al. 2011) and hyperthermic conditions (Pearson et al. 2013). 
For example, pharmacological unloading and loading of the baroreceptors, via decreasing 
(by ~18 mmHg) and increasing arterial blood pressure (by ~8 mmHg), causes ventilation to 
increase (by 9.7 ± 2.4 l min−1) and decrease (by 5.1 ± 1.1 l min−1), respectively (Stewart et 
al. 2011). The physiological significance of such a response may be the capacity of the 
respiratory pump to increase venous return and cardiac filling; that is, increasing respiration 
and subsequent generation of a more negative intrathoracic pressure aids cardiac filling and 
increases cardiac output as well as arterial and central venous pressures (CVP; Kilburn & 
Sieker, 1960; Moreno et al. 1967; Conway, 1975). Therefore, increased respiratory pump 
activation may be a protective mechanism triggered to optimize cardiac filling in conditions 
of central hypovolaemic hypotension (Convertino et al. 2009).
Hyperthermia and associated heat-dissipation mechanisms also reduce cardiac filling 
pressure, central blood volume and mean arterial pressure (MAP), consequently unloading 
the cardiopulmonary and arterial baroreceptors (Rowell et al. 1969; Wilson et al. 2007b; 
Ganio et al. 2011). Thus, prolonged hyperthermia-related hypotension and the corresponding 
unloading of baroreceptors may contribute to hyperthermic hyperventilation. However, the 
influence of baroreceptor unloading on hyperthermic hyperventilation has not been 
examined. In the present study, therefore, we tested the following hypothesis: 
cardiopulmonary baroreceptor unloading and arterial baroreceptor unloading during passive 
hyperthermia contribute to increases in ventilation and decreases in end-tidal partial pressure 
of carbon dioxide  during that exposure.
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Two protocols were undertaken for this study. For protocol 1, 10 subjects participated (three 
females; age, 29 ± 5 years; height, 177 ± 10 cm; and weight, 75.5 ± 12.2 kg). For protocol 2, 
11 subjects participated (five females; age, 26 ± 5 years; height, 178 ± 12 cm; and weight, 
71.3 ± 14.9 kg). Subjects were not taking medications, were free of any known 
cardiovascular, metabolic or neurological diseases and were non-smokers. As only within-
subject comparisons were performed (see ‘Data collection and statistics’ section), menstrual 
cycle phase was recorded but not controlled for in female subjects. Subjects were asked to 
abstain from exercise and alcohol for 24 h before testing, as well as caffeine for 12 h. Each 
subject was fully informed of the experimental procedures and possible risks before giving 
informed, written consent, but subjects were not informed of the proposed hypothesis. Both 
protocols and the informed consent were approved by the Institutional Review Boards at the 
University of Texas Southwestern Medical Center at Dallas and Texas Health Presbyterian 
Hospital of Dallas, and all procedures conformed to the standards set by the Declaration of 
Helsinki.
 Instrumentation
For both protocols, subjects were dressed in a long-sleeved and long-legged, two-piece, 
tube-lined perfusion suit (Med-Eng, Ottawa, ON, Canada), enabling the control of skin 
temperature and Tcore via the temperature of the water perfusing the suit. Measurements of 
Tcore were derived from a telemetry temperature pill swallowed ~2 h before the onset of data 
collection (HQ Inc., Palmetto, FL, USA). Whole-body mean skin temperature was measured 
from the weighted average of six thermocouples attached to the skin with porous adhesive 
tape on the calf (11%), thigh (14%), abdomen (14%), chest (22%), lower back (19%) and 
upper back (20%; Taylor et al. 1989). Expired air was sampled via a facemask attached to a 
two-way valve (Hans Rudolf, Inc., Shawnee, KS, USA). Ventilatory parameters (ventilation, 
tidal volume and breathing rate) were measured (body temperature and pressure saturated) 
using an automated gas analysis system (TrueOne 2400; Parvo-Medics, Sandy, UT, USA), 
with values recorded over 15 s epochs. The  was sampled from the mask and 
measured using a capnograph (9004 Capnocheck® Plus; Smiths Medical International Ltd, 
Watford, UK). Heart rate was collected from an ECG signal (Agilent, Munich, Germany) 
interfaced with a cardiotachometer (1000 Hz sampling rate; CWE, Ardmore, PA, USA). 
Beat-to-beat arterial blood pressure was measured and reconstructed to give brachial artery 
pressure via finger-cuff photoplethysmography (Finometer Pro; FMS, Amsterdam, The 
Netherlands or NexFin HD; BMEYE BV, Amsterdam, The Netherlands).
 Experimental protocol 1
This protocol was performed to determine whether reloading primarily the cardiopulmonary 
baroreceptors and increasing CVP would attenuate hyperthermic hyperventilation. In eight 
of the 10 subjects, a peripherally inserted central venous catheter was advanced into the 
superior vena cava via the basilic vein. Positioning of the central venous catheter was 
confirmed by the following observations: (i) the distance that the catheter was advanced 
relative to the subject’s height; (ii) adequate pressure waveforms; and (iii) an appropriate 
rapid rise and fall in pressure during a Valsalva and Müller manoeuvre, respectively. The 
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central venous catheter was connected to a pressure transducer and zeroed at the position of 
the mid-axillary line. This catheter was used for continuous measurement of CVP.
Following instrumentation, subjects rested in the supine position for a minimum of 30 min, 
while water at 34°C circulated through the suit. After ~20 min of wearing the facemask 
(ensuring steady-state ventilatory responses), normothermic baseline thermal, 
haemodynamic and respiratory measures were obtained. To minimize participant’s 
discomfort, the facemask was removed after these normothermic measurements. Subjects 
were then passively heated by circulating water at ~49°C through the suit. Between 10 and 
15 min into the passive heating phase, the facemask was re-attached, and ventilation and 
 were monitored for at least 20 min before hyperthermia measurements were taken 
(42 ± 13 and 33 ± 9 min in protocols 1 and 2, respectively). After Tcore had increased (1.9 
± 0.5°C) and there was a consistent increase in ventilation, associated with a ~5 mmHg 
reduction in , 19 ± 2 ml kg−1 warmed (~38°C) isotonic saline was rapidly 
administered over 6.9 ± 2.1 min through a separate catheter placed in an antecubital vein, as 
this rate and volume are sufficient to return CVP to pre-hyperthermic pressures (Crandall et 
al. 1999). The duration of the saline infusion differed between subjects (range, 5 – 10 min). 
After the infusion and subsequent data collection, skin surface cooling was performed by 
circulating water at ~20°C through the water-perfusion suit for 10 min. This method of 
cooling rapidly decreases the mean skin temperature with little initial effect on Tcore (see 
Results).
 Experimental protocol 2
This protocol was performed to determine whether reloading primarily the arterial 
baroreceptors and increasing MAP would attenuate hyperthermic hyperventilation. This 
protocol was almost identical to that outlined in the previous subsection; however, rather 
than administering warm saline, phenylephrine (PE; 60–120 μg min−1) was titrated 
intravenously for 5 min to increase MAP by 12 ± 3 mmHg. In protocol 2, participants lay 
supine with their lower legs off the end of the bed and their feet on a footstool, so that their 
knee angle was ~73 deg. This was done to aid venous pooling and augment hyperthermia-
related reductions in MAP. Also, mean skin temperature was gradually returned to pre-
hyperthermic stress levels 5 min after the PE infusion ended in order to avoid a potential 
hypertensive event that would otherwise occur with whole-body cooling in combination with 
the administered PE.
 Data collection and statistics
Data were acquired continuously at 50 Hz throughout the experiment (Biopac, Santa 
Barbara, CA, USA) and were reduced into the following 1 min periods: immediately before 
whole-body heating (normothermia); immediately before rapid saline infusion or PE 
administration (hyperthermia); and during rapid saline and PE infusions. The duration of 
rapid saline infusion differed between subjects; therefore, the final 5 min of the infusion are 
presented. All data were statistically analysed using one-way repeated-measures ANOVA 
with the repeated factor of time (normothermia, hyperthermia and the final 5 min of rapid 
saline or PE infusions), followed by Tukey-corrected post hoc tests when significant 
differences were identified. Additionally for protocol 1, the fifth minute of skin surface 
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cooling after the heat stress was analysed and compared using a one-way repeated-measures 
ANOVA with normothermia, hyperthermia and the final minute of rapid saline infusion. A 
skin surface cooling time point was not included in protocol 2 analysis on account of the 
gradual skin surface cooling employed. A linear regression analysis was performed to 
characterize further the relationship between changes in ventilation and CVP or MAP during 
rapid saline, skin surface cooling or PE infusion, respectively. Each subject’s change scores 
for ventilation, CVP (n = 8) and MAP (n = 11) were calculated from the difference between 
1 mi hyperthermic baseline and rapid saline infusion, skin surface cooling or PE infusion 
periods. Data were analysed using GraphPad Prism (version 6; GraphPad Software, Inc., La 
Jolla, CA, USA) with a priori statistical significance set at P ≤ 0.05. All data are reported as 
mean values ± SD.
 Results
 Protocol 1
Passive hyperthermia increased Tcore (by 1.9 ± 0.5°C, P < 0.01) and mean skin temperature 
(by 4.7 ± 0.7°C, P < 0.01) and decreased CVP (by 5 ± 1 mmHg, P < 0.01; Table 1 and Fig. 
1). This was accompanied by an increase in ventilation (by 2.2 ± 1.7 l min−1, P < 0.01) and 
tidal volume (by 0.4 ± 0.3 litres, P = 0.04), together with a reduction in  (by 4 ± 3 
mmHg, P = 0.04; Fig. 2) when compared with normothermia. Rapid infusion of 19 ± 2 ml 
kg−1 saline increased CVP (by 5 ± 1 mmHg, P < 0.01) but did not change ventilation (P = 
0.70) or  (P = 0.98) relative to pre-infusion hyperthermic values. The Tcore and mean 
skin temperature values were not different between hyperthermia and rapid infusion (P > 
0.05).
Skin surface cooling after the heat stress lowered mean skin temperature (by 4.7 ± 1.5°C, P 
< 0.01) but did not change Tcore (P = 0.99) from rapid infusion values. With skin surface 
cooling, CVP remained 5 ± 1 mmHg higher (P < 0.01) than pre-infusion hyperthermic 
values. Notably, skin surface cooling returned tidal volume (P = 0.98) and ventilation (P = 
0.52) to values similar to those in normothermia, but  remained slightly depressed 
(by 4 ± 2 mmHg, P = 0.01; Fig. 2. There was no association between increasing CVP and 
ventilation with either rapid saline infusion (r2 = 0.06, P = 0.55; Fig. 3A) or skin surface 
cooling (r2 = 0.05, P = 0.61; Fig. 3B).
 Protocol 2
Passive hyperthermia increased Tcore (by 1.8 ± 0.5°C, P < 0.01), increased mean skin 
temperature (by 6.0 ± 0.7°C, P < 0.01) and decreased MAP (by 9 ± 7 mmHg, P < 0.01; 
Table 2 and Fig. 4). This was accompanied by an increase in ventilation (by 5.0 ± 2.7 l 
min−1, P < 0.01) and a reduction in  (by 5 ± 2 mmHg, P <0.01). Relative to pre-
infusion hyperthermia, PE elevated MAP (by 12 ± 3 mmHg, P < 0.01), but did not change 
ventilation (P = 0.66) or  (P = 0.66; Fig. 5). The Tcore from hyperthermic values 
during the PE infusion (P = 0.93). There was a weak association between PE-induced 
increases in MAP and changes in ventilation (r2 = 0.33, P = 0.07; Fig. 6).
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This is the first study to examine whether cardiopulmonary or arterial baroreceptor 
unloading contributes to hyperthermic hyperventilation. The novel findings from this study 
are that hyperthermic hyperventilation is not mitigated by (i) expanding central blood 
volume and reloading the cardiopulmonary baroreceptors via rapid saline infusion, and (ii) 
reloading the arterial baroreceptors via PE administration. The absence of a reduction in 
ventilation during these perturbations indicates that cardiopulmonary or arterial baroreceptor 
unloading coincident with hyperthermia is unlikely to contribute to hyperthermic 
hyperventilation.
In the present study, participants’ hyperthermic hyperventilatory response following 
baroreceptor reloading varied in both protocols 1 and 2. In protocol 1, ventilation decreased 
to some extent in four of the eight participants with rapid infusion (Fig. 3A). Likewise, in 
protocol 2, ventilation decreased in seven of the 11 participants with PE infusion (Fig. 6). 
Thus, it may be that reloading the cardiopulmonary or the arterial baroreceptors attenuates 
hyperthermic hyperventilation in some individuals. Nevertheless, this interparticipant 
variation may also be due to various behavioural ventilatory influences (i.e. modulators 
largely unaffected by the homeostatic regulation of arterial blood gas tension; Shea, 1996). 
Interparticipant variation for the onset of hyperthermic hyperventilation has been reported 
previously (Fujii et al. 2008b). There also appear to be intraparticipant differences according 
to the type of hyperthermic stimulus, with passive hyperthermia inducing a greater 
hyperventilatory response in comparison to exercise (Fujii et al. 2008b). Thus, behavioural 
ventilatory control elements may prevail over hyperthermic physiological ventilator drivers 
in some individuals. Interestingly, PE-induced arterial baroreceptor reloading tended to be 
associated with a decrease in ventilation (r2 = 0.33). It has previously been shown that a 
bolus PE infusion decreases ventilation in normothermic conditions (Stewart et al. 2011). 
Thus, the presence of a ventilatory baroreflex may remain while an individual is 
hyperthermic; however, it remains unlikely that cardiopulmonary or arterial baroreceptor 
unloading contributes to hyperthermic hyperventilation in general.
Notably, rapid skin surface cooling restores  during severe hyperthermia (Tcore 
increased by 2°C) combined with lower body negative pressure (15 mmHg; Lucas et al. 
2010). Likewise, in the present study, skin surface cooling reduced tidal volume and 
ventilation from hyperthermic and rapid infusion values (Table 1). Rapid skin cooling elicits 
a pressor response whereby peripheral and visceral arteries constrict and central venous and 
right and left ventricular filling pressures increase (Wilson et al. 2007a,b). However, findings 
from the present study indicate that this pressor response is unlikely to contribute to 
reductions in hyperthermic hyperventilation with rapid skin cooling, as baroreceptor 
reloading alone did not attenuate hyperthermic hyperventilation. Given that hyperthermic 
hyperventilation is associated with high Tcore and skin temperatures (Cabanac & White, 
1995; Fujii et al. 2008b), it is possible that high thermoafferent activity from both the core 
and the skin may drive hyperthermic hyperventilation. Animal studies have shown that 
stimulation of hypothalamic thermosensitive neurons increases neural activity of the ventral 
respiratory group and, consequently, ventilation (Boden et al. 2000; Tryba & Ramirez, 
2003). If this is the case, presumably rapid skin cooling reduces hyperthermic 
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thermoafferent activity and, subsequently, some of the stimulus for hyperventilation. 
However, such a relationship between thermoafferent neural activity and ventilation has not 
been examined directly in humans. Alternatively, subjective relief from high skin 
temperatures with rapid skin cooling may also underlie reductions in hyperthermic 
hyperventilation. Hyperventilation can be associated with highly arousing negative emotions 
(Boiten et al. 1994), such as might be elicited from the great thermal discomfort 
accompanying elevated skin and body core temperatures. Thus, hyperthermic 
hyperventilation may not serve a physiological purpose, but rather is a response to a state of 
considerable thermal discomfort, anxiety and/or arousal. If this is the case, the relatively 
high cutaneous contribution to subjective thermal comfort may explain, in part, why rapid 
skin surface cooling reduces hyperventilation while Tcore remains elevated (Frank et al. 
1999). It may also explain the interparticipant variation in hyperthermic hyperventilation, as 
individuals with more experience and/or resilience (both physiologically and 
psychologically) to hyperthermia (for example, owing to habitual exercise in warm 
environments) may be better able to manage thermal discomfort and any resulting 
hyperthermic hyperventilation. Thus, perhaps hyperthermic hyperventilation indicates when 
an individual is reaching their psychophysiological hyperthermic limit.
 Technological considerations
Central venous pressure was measured in eight of the 10 subjects. As there is no reason to 
believe that CVP would respond differently during rapid saline infusion in the two subjects 
who refused the CVP catheter, we deemed it justifiable to include their data within the 
analyses.
In both protocols, rapid saline infusion and administration of PE were initiated when Tcore 
was very high (39.0 and 38.9°C, respectively). It is possible that such high Tcore and 
accompanying thermal discomfort dominated any potential baro-mediated ventilatory 
response. However, this magnitude of hyperthermia was necessary because hyperventilation 
was a prerequisite for testing our hypotheses. For the present study, we considered that a 
consistent increase in ventilation, associated with a ~5 mmHg reduction in , would 
be indicative of hyperthermic hyperventilation. We anticipated that this degree of 
hyperthermic hyperventilation would occur at a Tcore of 38–38.5°C based on previous 
studies (Cabanac & White, 1995; Fujii et al. 2008b). However, participants in the present 
study did not show a consistent hyperventilation until they reached a higher Tcore, indicative 
of the intraparticipant variability of this response (Fujii et al. 2008b). A possible explanation 
for this observation may be the facemask familiarization used in the present protocol. Each 
subject wore the facemask for at least 20 min prior to normothermic and hyperthermic data 
collection, thus reducing the likelihood of ‘artificially’ triggering hyperventilation and 
affecting the Tcore threshold for hyperthermic hyperventilation via application of the 
facemask.
Rapid skin surface cooling after heat stress increased  by 2 mmHg, but that value 
remained below the normothermic baseline, whereas at similar Tcore Lucas et al. (2010) 
found that  increased by 7 mmHg with skin surface cooling. This difference is likely 
to be due to the differences in the water temperature perfusing the suit, with use of 15°C 
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water as opposed to the 20°C water in the present study, determining that a more modest 
cooling stimulus elicited a smaller reduction in hyperthermic hyperventilation. In the present 
study, this was designed to avoid overloading the central vascular space and unsafely 
increasing central venous and arterial pressure, given the volume-loaded state of these 
individuals following saline infusion. For the same reason, skin temperature was lowered 
slowly in protocol 2; hence, no skin surface cooling data are presented. This further 
highlights the impact of reducing skin temperature on ventilator responses.
 Implications
Findings from the present study further highlight the importance of reducing high skin 
temperatures in hyperthermic individuals. Acute baroreceptor loading alone does not appear 
to circumvent hyperventilatory-induced hypocapnia, which affects cerebral perfusion owing 
to the cerebral vasoconstriction associated with reductions in arterial  (Kety & Schmidt, 
1948). However, this and previous studies indicate that lowering high skin temperatures in 
hyperthermic individuals attenuates hyperventilation (Lucas et al. 2010). This has 
ramifications for avoiding syncope and maintaining consciousness during a hyperthermic, 
hypotensive challenge.
Also, findings from the present study further support the intraparticipant variability 
associated with hyperthermic hyperventilation (Fujii et al. 2008b). This degree of variability 
coupled with a possible role of thermal discomfort in passive hyperthermic hyperventilation 
seem to indicate a psychophysical influence on hyperthermic hyperventilation. If this is the 
case, it may be that mental preparation or habituation, as has been observed in the cold 
(Croft et al. 2013), can affect an individual’s hyperthermic hyperventilatory threshold, which 
perhaps explains the variability of this response reported in the literature. However, a 
psychophysical effect has not been formally established to date.
 Conclusion
In the present study, rapid saline infusion and administration of PE successfully elevated 
CVP and MAP, respectively, ameliorating hyperthermia-related unloading of these 
baroreceptors. Despite this, ventilation and  did not change from pre-infusion 
hyperthermic values. These findings strongly indicate that hyperthermic hyperventilation is 
not affected by cardiopulmonary or arterial baroreceptor unloading coincident with 
hyperthermia.
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• What is the central question of this study?
Does baroreceptor unloading during passive hyperthermia contribute to 
increases in ventilation and decreases in end-tidal carbon dioxide 
during that exposure?
• What is the main finding and its importance?
Hyperthermic hyperventilation is not mitigated by expanding central 
blood volume and reloading the cardiopulmonary baroreceptors via 
rapid saline infusion or by reloading the arterial baroreceptors via 
phenylephrine administration. The absence of a reduction in ventilation 
upon reloading the baroreceptors to pre-hyperthermic levels indicates 
that cardiopulmonary and arterial baroreceptor unloading with 
hyperthermia is unlikely to contribute to hyperthermic hyperventilation 
in humans.
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Figure 1. Central venous pressure (n = 8) immediately prior to whole-body passive hyperthermia 
(normothermia), during hyperthermia alone and throughout the final 5 min of rapid saline 
infusion while hyperthermic
*Significantly different from normothermia, P < 0.05; and #significantly different from 
hyperthermia, P < 0.05.
Lucas et al. Page 12













Figure 2. Respiratory responses immediately prior to whole-body passive hyperthermia 
(normothermia), during hyperthermia alone and throughout the final 5 min of rapid saline 
infusion while hyperthermic
*Significantly different from normothermia, P < 0.05.
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Figure 3. The relationships between changes in ventilation and central venous pressure (CVP) 
following rapid saline infusion (relative to hyperthermia; A) and following skin surface cooling 
(relative to hyperthermia; B)
Data are individual responses to rapid saline infusion (n = 8).
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Figure 4. Mean arterial pressure immediately prior to whole-body passive hyperthermia 
(normothermia), during hyperthermia alone and throughout the first 5 min of phenylephrine 
infusion
*Significantly different from normothermia, P < 0.05; and #significantly different from 
hyperthermia, P < 0.05.
Lucas et al. Page 15













Figure 5. Respiratory responses immediately prior to whole-body passive hyperthermia 
(normothermia), during hyperthermia alone and throughout the first 5 min of phenylephrine 
infusion
*Significantly different from normothermia, P < 0.05.
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Figure 6. The relationships between changes in ventilation and Mean arterial pressure (MAP) 
following phenylephrine infusion (relative to hyperthermia)
Data are individual responses to PE infusion (n = 11).
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Table 1
Thermal, haemodynamic and respiratory parameters during normothermia, hyperthermia, rapid saline infusion 
and skin surface cooling for protocol 1
Parameter Normothermia Hyperthermia Rapid infusion Skin cooling
Body core temperature (°C) 37.0 ± 0.3 38.9 ± 0.4* 39.0 ± 0.5* 39.0 ± 0.5*
Mean skin temperature (°C) 34.7 ± 0.2 39.4 ± 0.8* 39.2 ± 0.8* 34.5 ± 0.9†‡
Mean arterial pressure (mmHg)    82 ± 8    79 ± 11    74 ± 8*    74 ± 8*
Heart rate (beats min−1)    59 ± 10  113 ± 17*  112 ± 14*    96 ± 13*†‡
*
Significantly different from normothermia P < 0.05;
†
significantly different from hyperthermia, P < 0.05;
‡
significantly different from rapid infusion, P < 0.05. Values are 1 min means ± SD.
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Table 2
Thermal and haemodynamic paramters during normothermia, hyperthermia and the fifth minute of 
phenylephrine infusion for protocol 2
Parameter Normothermia Hyperthermia PE infusion
Body core temperature (°C) 36.9 ± 0.2 38.7 ± 0.4* 38.9 ± 0.5*
Mean skin temperature (°C) 33.9 ± 0.5 39.9 ± 0.5* 39.8 ± 0.5*
Heart rate (beats min−1)    56 ± 10  107 ± 16*    95 ± 15*†
*
Significantly different from normothermia, P < 0.05;
†
significantly different from hyperthermia, P < 0.05. Values are 1 min means ± SD.
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